[1]
P. Chakrabarty, “Silymarin-choline combination versus ursodeoxycholic acid in non-alcoholic fatty liver disease: A randomized double-blind clinical trial”, Asian J Med Sci, vol. 15, no. 4, pp. 70–77, Apr. 2024.